1 | 1IKX | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE |
PNU |
|
SHOW |
2 | 1S6Q | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE |
TPB |
|
SHOW |
3 | 1S9E | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE |
ADB |
|
SHOW |
4 | 5TW3 | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-7-fluoronaphthalene-2-carbonitrile |
7N1 |
|
SHOW |
5 | 6DTW | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
|
SHOW |
6 | 6DTX | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
|
SHOW |
7 | 6UL5 | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenoxy}thieno[3,2-d]pyrimidin-2-yl)amino]-2-fluorobenzonitrile |
QAG |
|
SHOW |
8 | 6X47 | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
|
SHOW |
9 | 6X49 | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
|
SHOW |
10 | 6X4A | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
5-chloro-7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-8-methyl-2-naphthonitrile |
7AY |
|
SHOW |
11 | 6X4B | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-5-fluoro-8-methylnaphthalene-2-carbonitrile |
UMY |
|
SHOW |
12 | 6X4C | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-5,8-dimethylnaphthalene-2-carbonitrile |
UNS |
|
SHOW |
13 | 6X4D | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
5-(cyclopropylmethyl)-7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-8-methylnaphthalene-2-carbonitrile |
UO4 |
|
SHOW |
14 | 6X4E | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
methyl (6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)acetate |
UMV |
|
SHOW |
15 | 6X4F | Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 |
methyl (6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)acetate |
UMV |
|
SHOW |